Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from South-central in China

Journal of Antibiotics

Volumn 67, Issue 4, 2014, Pages 291-297

  Yu, Xiao Li ^a,b   Wen, Zi Lu ^a,b   Chen, Gao Zhan ^a   Li, Rui ^a   Ding, Bing Bing ^a   Yao, Yu Feng ^b   Li, Yao ^c   Wu, Hai ^c   Guo, Xiao Kui ^b   Wang, Hong Hai ^c   Zhang, Shu Lin ^b  

^a WUHAN POLYTECHNIC UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Beijing genotypes; extensively drug resistance; M. tuberculosis; multidrug resistance; mutation

Indexed keywords

ISONIAZID; RIFAMPICIN; RNA 16S; SPACER DNA;

ALLELE; ARTICLE; CHINA; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC MARKER; GENOTYPE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION;

ACADEMIC MEDICAL CENTERS; ALLELES; AMINO ACID SUBSTITUTION; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; CHINA; DNA, INTERGENIC; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PROMOTER REGIONS, GENETIC; RIFAMPIN; TUBERCULOSIS, PULMONARY;

EID: 84899707716     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2013.133     Document Type: Article

References (34)

1. WHO. Multidrug and Extensively Drug-Resistant tb (m/xdr-tb): 2010 Global Report on Surveillance and Response (World Health Organization, Geneva, WHO/HTM/TB, (2010)).
2. Zhao, Y. et al. National survey of drug-resistant tuberculosis in China. N. Engl. J. Med. 366, 2161-2170 (2012).
3. Drobniewski, F. A. & Wilson, S. M. The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis-a molecular story. J. Med. Microbiol. 47, 189-196 (1998).
4. Wade, M. M. & Zhang, Y. Mechanisms of drug resistance in Mycobacterium tuberculosis. Front Biosci. 9, 975-994 (2004).
5. Doustdar, F., Khosravi, A. D., Farnia, P., Masjedi, M. R. & Velayati, A. A. Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran. Microb Drug Resist. 14, 273-279 (2008).
6. Dalla Costa, E. R. et al. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol. 9, 39 (2009).
7. Dye, C., Williams, B. G., Espinal, M. A. & Raviglione, M. C. Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science 295, 2042-2046 (2002).
8. Zhang, S. L. et al. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates recovered from central China. Biochem. Genet. 45, 281-290 (2007).
9. Sajduda, A. et al. Molecular characterization of rifampin-and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J. Clin. Microbiol. 42, 2425-2431 (2004).
10. Metcalfe, J. Z. et al. Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007. Emerg. Infect. Dis. 16, 1403-1409 (2010).
11. Tian, L. L. et al. Molecular epidemiology of Mycobacterium tuberculosis in Gansu province of China. Chin. Med. J. 19, 3458-3464 (2012).
12. Laura, F. et al. Large sequence polymorphisms classify Mycobacterium tuberculosis strains with ancestral spoligotyping patterns. J. Clin. Microbiol. 10, 3393-3395 (2007)
13. NCCLS National committee for clinical laboratory standards (NCCLS, Wayne PA, 2003).
14. Singh, U., Akhtar, S. & Mishra, A. et al. A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents[J]. J. Microbiol. Methods 84, 202-207 (2011).
15. Peng, Y. L. et al. Detection of the rpsL mutation for streptomycin-resistant Mycobac-terium tuberculosis. Chin. J. Lab. Med. 23, 148-149 (2000).
16. Zhang, Z. Y. et al. Identification and pathogenicity analysis of a novel non-tuberculous mycobacterium clinical isolate with nine-antibiotic resistance. Clin. Microbiol. Infect. 19, 91-96 (2013).
17. Cole, S. T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544 (1998).
18. Tsolaki, A. G. et al. Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc. Natl Acad. Sci. USA 101, 4865-4870 (2004).
19. Abbadi, S. H., Sameaa, G. A., Morlock, G. & Cooksey, R. C. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Myco-bacterium tuberculosis. Int. J. Infect. Dis. 13, 673-678 (2009).
20. Hillemann, D., Weizenegger, M., Kubica, T., Richter, E. & Niemann, S. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 43, 3699-3703 (2005).
21. Jiao, W. W. et al. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin. Med. J. (Engl) 120, 814-819 (2007).
22. Homolka, S., Meyer, C. G. & Hillemann, D. et al. Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana. Int. J. Med. Microbiol. 300, 489-495 (2010).
23. Luo, T. et al. Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China. Antimicrob. Agents Chemother. 54, 1075-1081 (2010).
24. Bahrmand, A. R. et al. High-level rifampin resistance correlates with multiple mutations in the rpoB gene of pulmonary tuberculosis isolates from the Afghanistan border of Iran. J. Clin. Microbiol. 47, 2744-2750 (2009).
25. Sekiguchi, J. et al. Detection of multidrug resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 45, 179-192 (2007).
26. Dye, C. & Espinal, M. A. Will tuberculosis become resistant to all antibiotics? Proc. Biol. Sci. 268, 45-52 (2001).
27. Zhou, A. et al. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China. Microb. Drug. Resist. 17, 275-281 (2011).
28. Telenti, A. et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35, 719-723 (1997).
29. Van Rie, A. et al. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J. Clin. Microbiol. 39, 636-641 (2001).
30. Saribas, Z. et al. Use of fluorescence resonance energy transfer for rapid detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates. Int. J. Tuberc. Lung Dis. 9, 181-187 (2005).
31. Hazbon, M. H. et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 50, 2640-2649 (2006).
32. Sun, Z. et al. Characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates in China. J. Clin. Microbiol. 46, 4075-4077 (2008).
33. Khanna, A. et al. Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India. Antimicrob. Agents Chemother. 54, 4789-4793 (2010).
34. Muller, B. et al. inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa? Int. J. Tuberc. Lung Dis. 15, 344-351 (2011).